 | • レポートコード：MRC2012A1874 • 出版社/出版日：GlobalInfoResearch / 2020年12月21日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、135ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品、医療 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、セリアック病治療薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。セリアック病治療薬の種類別市場規模（膨満、下痢、食欲不振、その他）、用途別市場規模（一次治療、二次治療）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：F. Hoffmann-La Roche、Bayer、Pfizer、Johnson & Johnson、Anthera Pharmaceuticals、Merck、BioLineRx、Amgen、ADMA Biologics、Biogen、Novartis、Biotest、LFB Group、Takeda Pharmaceutical、Bristol-Myers Squibb、Kedrion Biopharma、Celgene、 ・地域別グローバル市場分析 2015年-2020年 ・セリアック病治療薬の北米市場（アメリカ、カナダ、メキシコ） ・セリアック病治療薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・セリアック病治療薬のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・セリアック病治療薬の南米市場（ブラジル、アルゼンチン） ・セリアック病治療薬の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：膨満、下痢、食欲不振、その他 ・用途別分析：一次治療、二次治療 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Celiac Disease Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Celiac Disease Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Celiac Disease Drug market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Celiac Disease Drug market has been segmented into
Distension
Diarrhea
Anorexia
Others
By Application, Celiac Disease Drug has been segmented into:
First line of treatment
Second line of treatment
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Celiac Disease Drug market presented in the report. This section sheds light on the sales growth of different regional and country-level Celiac Disease Drug markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Celiac Disease Drug market.
The report offers in-depth assessment of the growth and other aspects of the Celiac Disease Drug market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Celiac Disease Drug Market Share Analysis
Celiac Disease Drug competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Celiac Disease Drug sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Celiac Disease Drug sales, revenue and market share for each player covered in this report.
The major players covered in Celiac Disease Drug are:
F. Hoffmann-La Roche
Bayer
Pfizer
Johnson & Johnson
Anthera Pharmaceuticals
Merck
BioLineRx
Amgen
ADMA Biologics
Biogen
Novartis
Biotest
LFB Group
Takeda Pharmaceutical
Bristol-Myers Squibb
Kedrion Biopharma
Celgene
Among other players domestic and global, Celiac Disease Drug market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Celiac Disease Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Celiac Disease Drug, with price, sales, revenue and global market share of Celiac Disease Drug in 2018 and 2019.
Chapter 3, the Celiac Disease Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Celiac Disease Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Celiac Disease Drug market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Celiac Disease Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Celiac Disease Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Celiac Disease Drug Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Distension
1.2.3 Diarrhea
1.2.4 Anorexia
1.2.5 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Celiac Disease Drug Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 First line of treatment
1.3.3 Second line of treatment
1.4 Overview of Global Celiac Disease Drug Market
1.4.1 Global Celiac Disease Drug Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 F. Hoffmann-La Roche
2.1.1 F. Hoffmann-La Roche Details
2.1.2 F. Hoffmann-La Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 F. Hoffmann-La Roche SWOT Analysis
2.1.4 F. Hoffmann-La Roche Product and Services
2.1.5 F. Hoffmann-La Roche Celiac Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Bayer
2.2.1 Bayer Details
2.2.2 Bayer Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Bayer SWOT Analysis
2.2.4 Bayer Product and Services
2.2.5 Bayer Celiac Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Pfizer
2.3.1 Pfizer Details
2.3.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Pfizer SWOT Analysis
2.3.4 Pfizer Product and Services
2.3.5 Pfizer Celiac Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Johnson & Johnson
2.4.1 Johnson & Johnson Details
2.4.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Johnson & Johnson SWOT Analysis
2.4.4 Johnson & Johnson Product and Services
2.4.5 Johnson & Johnson Celiac Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Anthera Pharmaceuticals
2.5.1 Anthera Pharmaceuticals Details
2.5.2 Anthera Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Anthera Pharmaceuticals SWOT Analysis
2.5.4 Anthera Pharmaceuticals Product and Services
2.5.5 Anthera Pharmaceuticals Celiac Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Merck
2.6.1 Merck Details
2.6.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Merck SWOT Analysis
2.6.4 Merck Product and Services
2.6.5 Merck Celiac Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 BioLineRx
2.7.1 BioLineRx Details
2.7.2 BioLineRx Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 BioLineRx SWOT Analysis
2.7.4 BioLineRx Product and Services
2.7.5 BioLineRx Celiac Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Amgen
2.8.1 Amgen Details
2.8.2 Amgen Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Amgen SWOT Analysis
2.8.4 Amgen Product and Services
2.8.5 Amgen Celiac Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 ADMA Biologics
2.9.1 ADMA Biologics Details
2.9.2 ADMA Biologics Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 ADMA Biologics SWOT Analysis
2.9.4 ADMA Biologics Product and Services
2.9.5 ADMA Biologics Celiac Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Biogen
2.10.1 Biogen Details
2.10.2 Biogen Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Biogen SWOT Analysis
2.10.4 Biogen Product and Services
2.10.5 Biogen Celiac Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Novartis
2.11.1 Novartis Details
2.11.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Novartis SWOT Analysis
2.11.4 Novartis Product and Services
2.11.5 Novartis Celiac Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Biotest
2.12.1 Biotest Details
2.12.2 Biotest Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Biotest SWOT Analysis
2.12.4 Biotest Product and Services
2.12.5 Biotest Celiac Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 LFB Group
2.13.1 LFB Group Details
2.13.2 LFB Group Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 LFB Group SWOT Analysis
2.13.4 LFB Group Product and Services
2.13.5 LFB Group Celiac Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.14 Takeda Pharmaceutical
2.14.1 Takeda Pharmaceutical Details
2.14.2 Takeda Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Takeda Pharmaceutical SWOT Analysis
2.14.4 Takeda Pharmaceutical Product and Services
2.14.5 Takeda Pharmaceutical Celiac Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.15 Bristol-Myers Squibb
2.15.1 Bristol-Myers Squibb Details
2.15.2 Bristol-Myers Squibb Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Bristol-Myers Squibb SWOT Analysis
2.15.4 Bristol-Myers Squibb Product and Services
2.15.5 Bristol-Myers Squibb Celiac Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.16 Kedrion Biopharma
2.16.1 Kedrion Biopharma Details
2.16.2 Kedrion Biopharma Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 Kedrion Biopharma SWOT Analysis
2.16.4 Kedrion Biopharma Product and Services
2.16.5 Kedrion Biopharma Celiac Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.17 Celgene
2.17.1 Celgene Details
2.17.2 Celgene Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 Celgene SWOT Analysis
2.17.4 Celgene Product and Services
2.17.5 Celgene Celiac Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Celiac Disease Drug Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Celiac Disease Drug Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Celiac Disease Drug Manufacturer Market Share in 2019
3.3.2 Top 6 Celiac Disease Drug Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Celiac Disease Drug Sales, Revenue and Market Share by Regions
4.1.1 Global Celiac Disease Drug Sales and Market Share by Regions (2015-2020)
4.1.2 Global Celiac Disease Drug Revenue and Market Share by Regions (2015-2020)
4.2 North America Celiac Disease Drug Sales and Growth Rate (2015-2020)
4.3 Europe Celiac Disease Drug Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Celiac Disease Drug Sales and Growth Rate (2015-2020)
4.5 South America Celiac Disease Drug Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Celiac Disease Drug Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Celiac Disease Drug Sales, Revenue and Market Share by Country
5.1.1 North America Celiac Disease Drug Sales and Market Share by Country (2015-2020)
5.1.2 North America Celiac Disease Drug Revenue and Market Share by Country (2015-2020)
5.2 United States Celiac Disease Drug Sales and Growth Rate (2015-2020)
5.3 Canada Celiac Disease Drug Sales and Growth Rate (2015-2020)
5.4 Mexico Celiac Disease Drug Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Celiac Disease Drug Sales, Revenue and Market Share by Country
6.1.1 Europe Celiac Disease Drug Sales and Market Share by Country (2015-2020)
6.1.2 Europe Celiac Disease Drug Revenue and Market Share by Country (2015-2020)
6.2 Germany Celiac Disease Drug Sales and Growth Rate (2015-2020)
6.3 UK Celiac Disease Drug Sales and Growth Rate (2015-2020)
6.4 France Celiac Disease Drug Sales and Growth Rate (2015-2020)
6.5 Russia Celiac Disease Drug Sales and Growth Rate (2015-2020)
6.6 Italy Celiac Disease Drug Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Celiac Disease Drug Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Celiac Disease Drug Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Celiac Disease Drug Revenue and Market Share by Regions (2015-2020)
7.2 China Celiac Disease Drug Sales and Growth Rate (2015-2020)
7.3 Japan Celiac Disease Drug Sales and Growth Rate (2015-2020)
7.4 Korea Celiac Disease Drug Sales and Growth Rate (2015-2020)
7.5 India Celiac Disease Drug Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Celiac Disease Drug Sales and Growth Rate (2015-2020)
7.7 Australia Celiac Disease Drug Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Celiac Disease Drug Sales, Revenue and Market Share by Country
8.1.1 South America Celiac Disease Drug Sales and Market Share by Country (2015-2020)
8.1.2 South America Celiac Disease Drug Revenue and Market Share by Country (2015-2020)
8.2 Brazil Celiac Disease Drug Sales and Growth Rate (2015-2020)
8.3 Argentina Celiac Disease Drug Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Celiac Disease Drug Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Celiac Disease Drug Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Celiac Disease Drug Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Celiac Disease Drug Sales and Growth Rate (2015-2020)
9.3 Turkey Celiac Disease Drug Sales and Growth Rate (2015-2020)
9.4 Egypt Celiac Disease Drug Sales and Growth Rate (2015-2020)
9.5 South Africa Celiac Disease Drug Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Celiac Disease Drug Sales and Market Share by Type (2015-2020)
10.2 Global Celiac Disease Drug Revenue and Market Share by Type (2015-2020)
10.3 Global Celiac Disease Drug Price by Type (2015-2020)
11 Global Celiac Disease Drug Market Segment by Application
11.1 Global Celiac Disease Drug Sales Market Share by Application (2015-2020)
11.2 Global Celiac Disease Drug Revenue Market Share by Application (2015-2020)
11.3 Global Celiac Disease Drug Price by Application (2015-2020)
12 Market Forecast
12.1 Global Celiac Disease Drug Sales, Revenue and Growth Rate (2021-2025)
12.2 Celiac Disease Drug Market Forecast by Regions (2021-2025)
12.2.1 North America Celiac Disease Drug Market Forecast (2021-2025)
12.2.2 Europe Celiac Disease Drug Market Forecast (2021-2025)
12.2.3 Asia-Pacific Celiac Disease Drug Market Forecast (2021-2025)
12.2.4 South America Celiac Disease Drug Market Forecast (2021-2025)
12.2.5 Middle East & Africa Celiac Disease Drug Market Forecast (2021-2025)
12.3 Celiac Disease Drug Market Forecast by Type (2021-2025)
12.3.1 Global Celiac Disease Drug Sales Forecast by Type (2021-2025)
12.3.2 Global Celiac Disease Drug Market Share Forecast by Type (2021-2025)
12.4 Celiac Disease Drug Market Forecast by Application (2021-2025)
12.4.1 Global Celiac Disease Drug Sales Forecast by Application (2021-2025)
12.4.2 Global Celiac Disease Drug Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Celiac Disease Drug Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Celiac Disease Drug by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Celiac Disease Drug Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. F. Hoffmann-La Roche Basic Information, Manufacturing Base and Competitors
Table 8. F. Hoffmann-La Roche Celiac Disease Drug Major Business
Table 9. F. Hoffmann-La Roche Celiac Disease Drug Total Revenue (USD Million) (2017-2018)
Table 10. F. Hoffmann-La Roche SWOT Analysis
Table 11. F. Hoffmann-La Roche Celiac Disease Drug Product and Services
Table 12. F. Hoffmann-La Roche Celiac Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Bayer Basic Information, Manufacturing Base and Competitors
Table 14. Bayer Celiac Disease Drug Major Business
Table 15. Bayer Celiac Disease Drug Total Revenue (USD Million) (2017-2018)
Table 16. Bayer SWOT Analysis
Table 17. Bayer Celiac Disease Drug Product and Services
Table 18. Bayer Celiac Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Pfizer Basic Information, Manufacturing Base and Competitors
Table 20. Pfizer Celiac Disease Drug Major Business
Table 21. Pfizer Celiac Disease Drug Total Revenue (USD Million) (2017-2018)
Table 22. Pfizer SWOT Analysis
Table 23. Pfizer Celiac Disease Drug Product and Services
Table 24. Pfizer Celiac Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 26. Johnson & Johnson Celiac Disease Drug Major Business
Table 27. Johnson & Johnson Celiac Disease Drug Total Revenue (USD Million) (2017-2018)
Table 28. Johnson & Johnson SWOT Analysis
Table 29. Johnson & Johnson Celiac Disease Drug Product and Services
Table 30. Johnson & Johnson Celiac Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Anthera Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 32. Anthera Pharmaceuticals Celiac Disease Drug Major Business
Table 33. Anthera Pharmaceuticals Celiac Disease Drug Total Revenue (USD Million) (2017-2018)
Table 34. Anthera Pharmaceuticals SWOT Analysis
Table 35. Anthera Pharmaceuticals Celiac Disease Drug Product and Services
Table 36. Anthera Pharmaceuticals Celiac Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Merck Basic Information, Manufacturing Base and Competitors
Table 38. Merck Celiac Disease Drug Major Business
Table 39. Merck Celiac Disease Drug Total Revenue (USD Million) (2017-2018)
Table 40. Merck SWOT Analysis
Table 41. Merck Celiac Disease Drug Product and Services
Table 42. Merck Celiac Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. BioLineRx Basic Information, Manufacturing Base and Competitors
Table 44. BioLineRx Celiac Disease Drug Major Business
Table 45. BioLineRx Celiac Disease Drug Total Revenue (USD Million) (2017-2018)
Table 46. BioLineRx SWOT Analysis
Table 47. BioLineRx Celiac Disease Drug Product and Services
Table 48. BioLineRx Celiac Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Amgen Basic Information, Manufacturing Base and Competitors
Table 50. Amgen Celiac Disease Drug Major Business
Table 51. Amgen Celiac Disease Drug Total Revenue (USD Million) (2017-2018)
Table 52. Amgen SWOT Analysis
Table 53. Amgen Celiac Disease Drug Product and Services
Table 54. Amgen Celiac Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. ADMA Biologics Basic Information, Manufacturing Base and Competitors
Table 56. ADMA Biologics Celiac Disease Drug Major Business
Table 57. ADMA Biologics Celiac Disease Drug Total Revenue (USD Million) (2017-2018)
Table 58. ADMA Biologics SWOT Analysis
Table 59. ADMA Biologics Celiac Disease Drug Product and Services
Table 60. ADMA Biologics Celiac Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Biogen Basic Information, Manufacturing Base and Competitors
Table 62. Biogen Celiac Disease Drug Major Business
Table 63. Biogen Celiac Disease Drug Total Revenue (USD Million) (2017-2018)
Table 64. Biogen SWOT Analysis
Table 65. Biogen Celiac Disease Drug Product and Services
Table 66. Biogen Celiac Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Novartis Basic Information, Manufacturing Base and Competitors
Table 68. Novartis Celiac Disease Drug Major Business
Table 69. Novartis Celiac Disease Drug Total Revenue (USD Million) (2017-2018)
Table 70. Novartis SWOT Analysis
Table 71. Novartis Celiac Disease Drug Product and Services
Table 72. Novartis Celiac Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. Biotest Basic Information, Manufacturing Base and Competitors
Table 74. Biotest Celiac Disease Drug Major Business
Table 75. Biotest Celiac Disease Drug Total Revenue (USD Million) (2017-2018)
Table 76. Biotest SWOT Analysis
Table 77. Biotest Celiac Disease Drug Product and Services
Table 78. Biotest Celiac Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 79. LFB Group Basic Information, Manufacturing Base and Competitors
Table 80. LFB Group Celiac Disease Drug Major Business
Table 81. LFB Group Celiac Disease Drug Total Revenue (USD Million) (2017-2018)
Table 82. LFB Group SWOT Analysis
Table 83. LFB Group Celiac Disease Drug Product and Services
Table 84. LFB Group Celiac Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 85. Takeda Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 86. Takeda Pharmaceutical Celiac Disease Drug Major Business
Table 87. Takeda Pharmaceutical Celiac Disease Drug Total Revenue (USD Million) (2017-2018)
Table 88. Takeda Pharmaceutical SWOT Analysis
Table 89. Takeda Pharmaceutical Celiac Disease Drug Product and Services
Table 90. Takeda Pharmaceutical Celiac Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 91. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 92. Bristol-Myers Squibb Celiac Disease Drug Major Business
Table 93. Bristol-Myers Squibb Celiac Disease Drug Total Revenue (USD Million) (2017-2018)
Table 94. Bristol-Myers Squibb SWOT Analysis
Table 95. Bristol-Myers Squibb Celiac Disease Drug Product and Services
Table 96. Bristol-Myers Squibb Celiac Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 97. Kedrion Biopharma Basic Information, Manufacturing Base and Competitors
Table 98. Kedrion Biopharma Celiac Disease Drug Major Business
Table 99. Kedrion Biopharma Celiac Disease Drug Total Revenue (USD Million) (2017-2018)
Table 100. Kedrion Biopharma SWOT Analysis
Table 101. Kedrion Biopharma Celiac Disease Drug Product and Services
Table 102. Kedrion Biopharma Celiac Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 103. Celgene Basic Information, Manufacturing Base and Competitors
Table 104. Celgene Celiac Disease Drug Major Business
Table 105. Celgene Celiac Disease Drug Total Revenue (USD Million) (2017-2018)
Table 106. Celgene SWOT Analysis
Table 107. Celgene Celiac Disease Drug Product and Services
Table 108. Celgene Celiac Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 109. Global Celiac Disease Drug Sales by Manufacturer (2018-2019) (K Pcs)
Table 110. Global Celiac Disease Drug Revenue by Manufacturer (2018-2019) (USD Million)
Table 111. Global Celiac Disease Drug Sales by Regions (2015-2020) (K Pcs)
Table 112. Global Celiac Disease Drug Sales Market Share by Regions (2015-2020)
Table 113. Global Celiac Disease Drug Revenue by Regions (2015-2020) (USD Million)
Table 114. North America Celiac Disease Drug Sales by Countries (2015-2020) (K Pcs)
Table 115. North America Celiac Disease Drug Sales Market Share by Countries (2015-2020)
Table 116. North America Celiac Disease Drug Revenue by Countries (2015-2020) (USD Million)
Table 117. North America Celiac Disease Drug Revenue Market Share by Countries (2015-2020)
Table 118. Europe Celiac Disease Drug Sales by Countries (2015-2020) (K Pcs)
Table 119. Europe Celiac Disease Drug Sales Market Share by Countries (2015-2020)
Table 120. Europe Celiac Disease Drug Revenue by Countries (2015-2020) (USD Million)
Table 121. Asia-Pacific Celiac Disease Drug Sales by Regions (2015-2020) (K Pcs)
Table 122. Asia-Pacific Celiac Disease Drug Sales Market Share by Regions (2015-2020)
Table 123. Asia-Pacific Celiac Disease Drug Revenue by Regions (2015-2020) (USD Million)
Table 124. South America Celiac Disease Drug Sales by Countries (2015-2020) (K Pcs)
Table 125. South America Celiac Disease Drug Sales Market Share by Countries (2015-2020)
Table 126. South America Celiac Disease Drug Revenue by Countries (2015-2020) (USD Million)
Table 127. South America Celiac Disease Drug Revenue Market Share by Countries (2015-2020)
Table 128. Middle East & Africa Celiac Disease Drug Sales by Countries (2015-2020) (K Pcs)
Table 129. Middle East & Africa Celiac Disease Drug Sales Market Share by Countries (2015-2020)
Table 130. Middle East & Africa Celiac Disease Drug Revenue by Countries (2015-2020) (USD Million)
Table 131. Middle East & Africa Celiac Disease Drug Revenue Market Share by Countries (2015-2020)
Table 132. Global Celiac Disease Drug Sales by Type (2015-2020) (K Pcs)
Table 133. Global Celiac Disease Drug Sales Share by Type (2015-2020)
Table 134. Global Celiac Disease Drug Revenue by Type (2015-2020) (USD Million)
Table 135. Global Celiac Disease Drug Revenue Share by Type (2015-2020)
Table 136. Global Celiac Disease Drug Sales by Application (2015-2020) (K Pcs)
Table 137. Global Celiac Disease Drug Sales Share by Application (2015-2020)
Table 138. Global Celiac Disease Drug Sales Forecast by Regions (2021-2025) (K Pcs)
Table 139. Global Celiac Disease Drug Market Share Forecast by Regions (2021-2025)
Table 140. Global Celiac Disease Drug Sales Forecast by Type (2021-2025) (K Pcs)
Table 141. Global Celiac Disease Drug Market Share Forecast by Type (2021-2025)
Table 142. Global Celiac Disease Drug Sales Forecast by Application (2021-2025)
Table 143. Global Celiac Disease Drug Market Share Forecast by Application (2021-2025)
Table 144. Direct Channel Pros & Cons
Table 145. Indirect Channel Pros & Cons
Table 146. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Celiac Disease Drug Picture
Figure 2. Global Sales Market Share of Celiac Disease Drug by Type in 2019
Figure 3. Distension Picture
Figure 4. Diarrhea Picture
Figure 5. Anorexia Picture
Figure 6. Others Picture
Figure 7. Celiac Disease Drug Sales Market Share by Application in 2018
Figure 8. First line of treatment Picture
Figure 9. Second line of treatment Picture
Figure 10. Global Celiac Disease Drug Market Status and Outlook (2015-2025) (USD Million)
Figure 11. United States Celiac Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Canada Celiac Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Mexico Celiac Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Germany Celiac Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 15. France Celiac Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 16. UK Celiac Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Russia Celiac Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Italy Celiac Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 19. China Celiac Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Japan Celiac Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Korea Celiac Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 22. India Celiac Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Southeast Asia Celiac Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Australia Celiac Disease Drug Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 25. Brazil Celiac Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Egypt Celiac Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Saudi Arabia Celiac Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 28. South Africa Celiac Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Turkey Celiac Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Global Celiac Disease Drug Sales Market Share by Manufacturer in 2019
Figure 31. Global Celiac Disease Drug Revenue Market Share by Manufacturer in 2019
Figure 32. Top 3 Celiac Disease Drug Manufacturer (Revenue) Market Share in 2019
Figure 33. Top 6 Celiac Disease Drug Manufacturer (Revenue) Market Share in 2019
Figure 34. Key Manufacturer Market Share Trend
Figure 35. Global Celiac Disease Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 36. Global Celiac Disease Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 37. Global Celiac Disease Drug Revenue Market Share by Regions (2015-2020)
Figure 38. Global Celiac Disease Drug Revenue Market Share by Regions in 2018
Figure 39. North America Celiac Disease Drug Sales and Growth Rate (2015-2020)
Figure 40. Europe Celiac Disease Drug Sales and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Celiac Disease Drug Sales and Growth Rate (2015-2020)
Figure 42. South America Celiac Disease Drug Sales and Growth Rate (2015-2020)
Figure 43. Middle East & Africa Celiac Disease Drug Sales and Growth Rate (2015-2020)
Figure 44. North America Celiac Disease Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 45. North America Celiac Disease Drug Sales Market Share by Countries (2015-2020)
Figure 46. North America Celiac Disease Drug Sales Market Share by Countries in 2018
Figure 47. North America Celiac Disease Drug Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 48. North America Celiac Disease Drug Revenue Market Share by Countries in 2018
Figure 49. United States Celiac Disease Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 50. Canada Celiac Disease Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 51. Mexico Celiac Disease Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 52. Europe Celiac Disease Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 53. Europe Celiac Disease Drug Revenue Market Share by Countries (2015-2020)
Figure 54. Europe Celiac Disease Drug Revenue Market Share by Countries in 2019
Figure 55. Germany Celiac Disease Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 56. UK Celiac Disease Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 57. France Celiac Disease Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 58. Russia Celiac Disease Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 59. Italy Celiac Disease Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 60. Asia-Pacific Celiac Disease Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 61. Asia-Pacific Celiac Disease Drug Sales Market Share by Regions 2019
Figure 62. Asia-Pacific Celiac Disease Drug Revenue Market Share by Regions 2019
Figure 63. China Celiac Disease Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 64. Japan Celiac Disease Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 65. Korea Celiac Disease Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 66. India Celiac Disease Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 67. Southeast Asia Celiac Disease Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 68. South America Celiac Disease Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 69. South America Celiac Disease Drug Sales Market Share by Countries in 2019
Figure 70. South America Celiac Disease Drug Revenue Market Share by Countries in 2019
Figure 71. Brazil Celiac Disease Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 72. Argentina Celiac Disease Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 73. Middle East and Africa Celiac Disease Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 74. Middle East and Africa Celiac Disease Drug Sales Market Share by Countries in 2019
Figure 75. Middle East and Africa Celiac Disease Drug Revenue Market Share by Countries (2015-2020)
Figure 76. Middle East and Africa Celiac Disease Drug Revenue Market Share by Countries in 2019
Figure 77. Saudi Arabia Celiac Disease Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 78. Egypt Celiac Disease Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 79. Turkey Celiac Disease Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 80. South Africa Celiac Disease Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 81. Global Celiac Disease Drug Sales and Growth Rate (2021-2025) (K Pcs)
Figure 82. Global Celiac Disease Drug Revenue and Growth Rate (2021-2025) (USD Million)
Figure 83. North America Sales Celiac Disease Drug Market Forecast (2021-2025) (K Pcs)
Figure 84. Europe Sales Celiac Disease Drug Market Forecast (2021-2025) (K Pcs)
Figure 85. Asia-Pacific Sales Celiac Disease Drug Market Forecast (2021-2025) (K Pcs)
Figure 86. South America Sales Celiac Disease Drug Market Forecast (2021-2025) (K Pcs)
Figure 87. Middle East & Africa Sales Celiac Disease Drug Market Forecast (2021-2025) (K Pcs)
Figure 88. Sales Channel: Direct Channel vs Indirect Channel
セリアック病治療薬の世界市場（～2026年） Market Analysis and Insights: Global Celiac Disease Drug Market The global Celiac Disease Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Celiac Disease Drug Scope and Market Size Celiac Disease Drug market is seg…- セリアック病の世界市場（～2026年） Market Analysis and Insights: Global Celiac Disease Market The global Celiac Disease market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Celiac Disease Scope and Market Size Celiac Disease market is segmented by Type, and …
- セリアック治療薬の世界市場（～2026年） Celiac disease, also known as celiac sprue or gluten-sensitive enteropathy, is a genetic autoimmune disorder caused due to the body’s inability to process gluten that causes damage to the small intestine. Gluten, a protein found in wheat, barley, and rye, can damage the lining of the small intestine…
- 胃食道逆流症治療薬及びデバイスの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Gastro Esophageal Reflux Disease Drug and Devices market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.…
- クローン病治療薬の世界市場（～2026年） Market Analysis and Insights: Global Crohn’s Disease Drug Market The global Crohn’s Disease Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Crohn’s Disease Drug Scope and Market Size Crohn’s Disease Drug market is…